Cargando…
Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
Treatment with glucocorticoid (GC) is the preferred therapy for polymyalgia rheumatica (PMR), but some patients show poor responses to the initial GC regimen or experience flares on GC tapering. Alternative therapies for patients with GC resistance have not yet been established. To evaluate pretreat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844628/ https://www.ncbi.nlm.nih.gov/pubmed/24803231 http://dx.doi.org/10.1007/s10067-014-2650-y |